A center focused on using the immune system to fight cancer
Center for Cancer Immunology and Immunotherapy (CCII)
The University of Louisville's Center for Cancer Immunology and Immunotherapy is working on new ways to help cancer patients by using their own immune systems to fight cancer, testing exciting treatments that could lead to lasting improvements or even cures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-10771211 on NIH RePORTER |
What this research studies
The Center for Cancer Immunology and Immunotherapy at the University of Louisville aims to advance cancer treatment by harnessing the immune system's power to combat various types of cancer. This multidisciplinary center will conduct innovative biomedical research, exploring therapies such as immune checkpoint inhibitors and adoptive cell transfer. By utilizing human specimens from clinical trials and leveraging the expertise of seasoned investigators, the center seeks to develop effective immunotherapies that can lead to long-lasting remissions or cures for cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals diagnosed with various types of cancer who may be eligible for immunotherapy treatments.
Not a fit: Patients with non-malignant conditions or those who do not have a cancer diagnosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking immunotherapy treatments that significantly improve cancer outcomes.
How similar studies have performed: Other research has shown promising results with similar immunotherapy approaches, indicating a strong potential for success in this area.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Yan, Jun — University of Louisville
- Study coordinator: Yan, Jun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.